Characteristics of circulating γδ T cells from individuals chronically infected with hepatitis C Vir

来源 :第九届全国肝脏疾病临床学术大会 | 被引量 : 0次 | 上传用户:liongliong499
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Background and Aims Chronic inflammation associated with hepatitis C virus (HCV) infection may lead to cirrhosis liver failure,or hepatocarcinoma;however,the pathogenic mechanism(s) involved in HCV immunopathology has not been completely understood.The current study explored the phenotypic and functional characteristics of γδ T cells and investigated their impact on liver pathology in chronically HCV-infected patients.Methods Blood samples were obtained from 51 patients with chronic HCV infection and 39 healthy volunteers (controls).The numeric,phenotypic and functional characteristics ofγδ T cells,subtype Vδ1 γδ T or Vδ2 γδ T were analyzed and we also investigated whether these immunological parameters were associated with clinical parameters (plasma viremia,ALT levels).Results We found that the proportion ofγδ T cells in blood samples from HCV-infected patients (7.77%) was much higher than in samples from healthy controls (4.01%;P < 0.05).This increase was due to expansion of subtype Vδ2 γδ T cells (6.57% vs 3.43%;P < 0.05),whilst Vδ1 γδ T cells were unchanged (0.898% vs 0.968%;P =0.4046).The percentage and absolute number of Vδ2 γδ T cells were positively correlated with serum ALT levels (r =0A049;P < 0.01 andr =0.3998;P< 0.01),but not with serum HCV RNA (r =0.0236;P =0.8822 andr =0.1646;P=0.2915).No correlation was found between the percentage and number of Vδ1 γδ T with either semmALTlevels or HCV RNA.Vδ2 γδ T cells from HCV-infected patients displayed an activated phenotype,which was indicated by increased expression of activation markers such as CD38,HLA-DR and CD69.Further analysis showed that Vδ2 γδ T cells from HCV-infected patients exhibited higher capacity to kill HepG2 targets in comparison with those from healthy subjects.Conclusion In HCV-infected patients,Vδ2 γδ T cells are activated and demonstrated enhanced eytolytic activity and might participate in liver injury during chronic HCV infection.These findings provide novel information regarding the pathogenesis of HCV infection.
其他文献
会议
目的:研究旨在揭示中药提取物肃毒星的体内外抗乙型肝炎病毒(HBV)作用及其相关作用机制.方法:以HepG2.2.15细胞(野生型HBV复制细胞系)和HepG2.A64细胞(恩替卡韦耐药型HBV复制细胞系)作为肃毒星抗HBV作用的体外评价模型;将携带1.3个拷贝HBV基因组信息的重组8型腺相关病毒经小鼠的尾静脉注射建立HBV小鼠体内评价模型.分别用荧光定量PCR、ELISA和免疫组化方法检测细胞HB
BACKGROUND: Treatment of chronic hepatitis C (CHC) with pegylated interferon-alpha/ribavirin is associated with wellcharacterized dermatological adverse events (AEs),which can lead to premature discon
目的:肝细胞性肝癌(Hepatocellular carcinoma,HCC)预后较差,治疗方法是以手术为主,化疗和放疗相结合的综合治疗,因伴有多药耐药性(Multiple drug resistance,MDR),使多种化疗药物疗效降低甚至无效.寻找特异靶点逆转MDR提高化疗敏感性已是HCC治疗热点.存在于高尔基氏体的聚集素(Clusterin,CLU)是一种具有多种生物学功能的异源二聚体硫酸化
目的:NF-κB为结合于免疫球蛋白κ轻链增强子上的核蛋白,由RelA(p65)、RelB、C-Rel、NF-κB1(p50)和NF-κB2(p52)等亚基组成,其中p50/p65最常见,p65与DNA结合后可直接作用于C末端转录元件而激活转录过程.静止期胞浆NF-κB与抑制蛋白I κB形成三聚体.当肝细胞受到肝炎病毒感染时,激活的NF-κB进入胞核与特定κB位点靶基因结合,发挥转录调节和介导免疫、
目的:探讨荔枝核总黄酮(TFL)对胆总管结扎(BDL)所致肝纤维化大鼠肝功能、核因子-κB(NF-κB)和Ⅲ型前胶原(PCⅢ)蛋白表达的影响.方法:以双重结扎胆总管结间剪断法造模,60只SD大鼠随机分为六组,每组10只,分别为:胆总管结扎组(BDL组),荔枝核总黄酮组(TFL小、中、大剂量组),水飞蓟宾组(SIL组),以假手术组(SO组)为阴性对照.造模后第2天TFL小、中、大剂量组和SIL组分别
目的:观察异甘草酸镁(MgIG)对大鼠肝细胞模拟缺血再灌注损伤的细胞凋亡影响及其机制.方法:分离、培养、鉴定大鼠肝细胞,将对数生长期肝细胞,随机分为模拟缺血再灌注损伤模型组和MgIG低浓度组(0.1mg/ml)、中浓度组(1mg/ml)、高浓度组(10mg/ml)预处理24h后,模拟缺氧6h、复氧4h,进行以下实验观察:①应用光镜观察细胞的形态改变;②应用四甲基偶氮唑盐(MTT)法检测MgIG对肝
目的:探讨在B超引导下经皮肝包膜下注射多次移植骨髓间充质干细胞(BMSCs)的方法及对大鼠肝损伤的治疗作用.方法:四氯化碳(CCl4)皮下注射建立肝损伤大鼠模型.首次移植:手术开腹,在肝损伤大鼠肝包膜下注入lmL含BMSCs胶原培养液(BMSCs移植组);在肝损伤大鼠和正常大鼠肝包膜下分别注入1mL不含BMSCs胶原培养液(分别为肝损伤对照组和正常对照组).第2次和第3次移植:分别在首次移植后第3
Background and Aim Hepatocellular carcinoma (HCC) is one of the most common malignancies worldwide.Most hepatocellular carcinomas develop in the background of the advanced liver fibrosis and cirrhosis
目的 增强HBV慢性感染时T细胞的功能,成为HBV感染研究的热点和关键.本研究分析HBV感染后,核苷酸内焦磷酸酶2/溶血磷脂酸轴与病毒载量、病毒特异的CD4+T细胞和CD8+T细胞之间的相关性,探讨核苷酸内焦磷酸酶2/溶血磷脂酸轴参与调节细胞免疫的机制.方法 用pcDNA3.1-HBV1.3质粒瞬时转染HepG2和Huh-7细胞,在细胞水平上验证ENPP2(核苷酸内焦磷酸酶/磷酸二酯酶2)蛋白与病